What are the best treatments for Thyroid cancer?

The primary treatment for thyroid cancer is surgical resection, often followed by radioactive iodine therapy and lifelong thyroid hormone replacement. Treatment plans for thyroid cancer must be highly personalized based on the histological subtype, tumor stage, and the patient's individual health profile.

What are the standard first-line treatments for thyroid cancer?

For most patients diagnosed with differentiated thyroid cancer (papillary or follicular), the first-line treatment is a thyroidectomy (surgical removal of the thyroid gland). Depending on the tumor size and spread, surgeons may remove the entire gland or a lobe. Following surgery, endocrinologists often prescribe levothyroxine (Synthroid, Levoxyl) to replace natural hormones and suppress thyroid-stimulating hormone (TSH) levels, which can help prevent recurrence.

What additional therapies are used for thyroid cancer?

When there is a risk of microscopic disease or for more aggressive forms of thyroid cancer, the following treatments are common:

• Radioactive Iodine (RAI) Therapy: Uses iodine-131 to destroy remaining cancerous thyroid cells.


• External Beam Radiation: Used primarily for advanced cases or if the cancer does not respond to RAI.


• Targeted Therapy: For advanced, RAI-refractory cases, kinase inhibitors like lenvatinib (Lenvima) or sorafenib (Nexavar) may be utilized.


• Active Surveillance: In select, low-risk cases of micro-papillary thyroid cancer, doctors may monitor the tumor closely rather than operating immediately.

Which specialists should be on my care team?

Managing thyroid cancer requires a multidisciplinary approach to ensure the best outcomes. Your care team should ideally include an endocrinologist, an endocrine surgeon or head and neck surgeon, a nuclear medicine specialist, and an oncologist specializing in endocrine malignancies. At DiseaseMaps.org, 39 members have shared their experiences, highlighting the importance of building a supportive team that addresses both physical and emotional well-being.

How does treatment effectiveness vary?

Treatment effectiveness is highly dependent on the specific type of thyroid cancer. While differentiated thyroid cancer has a high survival rate (often exceeding 95% at 10 years), medullary and anaplastic variants require much more intensive and specialized management. Genetic testing for mutations (such as BRAF or RET) is increasingly used to predict how a patient will respond to certain targeted therapies.

Next steps

• Consult with an endocrinologist to discuss your specific pathology report and staging.


• Inquire about genetic testing for your tumor to determine if targeted therapies are appropriate.


• Connect with the 39 other patients at DiseaseMaps.org to share experiences and coping strategies.


• Maintain a consistent schedule for blood work to monitor your TSH and thyroglobulin levels.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare provider for personalized treatment decisions.

References

• American Thyroid Association (ATA) Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer


• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Thyroid Carcinoma


• National Cancer Institute (NCI) PDQ® Cancer Information Summaries